Skip to main content
Equibles

ALVO · Alvotech · Metrics

Track ALVO — free

Use ALVO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ALVO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.86 +0.31 (+6.81%) At close · Nov 6 Play latest call Q2 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$1.73B
Shares
356.82M
Volume · Nov 6 1.02M Avg daily vol (3M) 1.05M

ALVO metrics

61 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$4.86
Market cap
$1.73B

Price action

23 metrics
Price change (1W)
+4.5%
Price change (30D)
-14.3%
Price change (3M)
+27.6%
Price change (6M)
+49.1%
Price change (YTD)
-5.3%
Price change (1Y)
-4.0%
Trailing year
Price change (5Y)
—
52-week high
$6.15
52-week low
$3.00
Change from 52-week high
-21.0%
Change from 52-week low
+62.0%
Annualized volatility
71.8%
Annualized volatility (3M)
69.0%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
0.9
RSI (14D)
47.4
Price vs SMA 50
-8.1%
Price vs SMA 200
+15.7%
Avg volume (3M)
1.05M
Relative volume
1.0
Average dollar volume
$5.45M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
356.82M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.5×
reciprocal yield 28.4%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-12
Last earnings
2026-08-20

Profitability

9 metrics
Gross margin
60.4%
Operating margin
9.7%
Trailing 12 months
Net margin
4.8%
Gross profit (TTM)
$297.38M
Operating profit (TTM)
$47.54M
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-0.91

Growth

11 metrics
Revenue growth YoY
+19.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$491.95M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+3.4%
Year over year · more shares
Revenue CAGR (3Y)
+91.9%
Revenue CAGR (5Y)
+54.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
1.9%
Debt / equity
—
Current ratio
1.6
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
1.0
Interest coverage
0.3
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$172.36M
Total assets
$1.59B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
$62.67M
R&D (TTM)
$137.67M
SG&A (TTM)
—
Stock compensation (TTM)
$9.22M
R&D / revenue
28.0%
Stock compensation / revenue
1.9%

Ownership (13F)

9 metrics
13F filers
76
13F filer change QoQ
+15
Institutional ownership
13.4%
Conviction holders (share of 13F filers)
2.8%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+246.4%
Holder tenure
5.4
Price vs estimated holder cost
-26.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
1.0%

Short interest

3 metrics
Short interest
1.8%
Latest settlement · 5.7 days to cover
Days to cover
5.7d
Short-squeeze score
60 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1898416 CUSIP L01800108 13F (30d) 22 filings 22 filers Visit website Investor relations